An analyst said companies like Dabur, which has a 9-12 per cent exposure to ayurvedic products, and Emami, were expecting a tax rate in the lower end.“Emami, which has been trying to grow its Zandu brand, will take a pause now,” the analyst said.
Zandu and Mentho Plus balms command a 59 per cent share of the Rs 900 crore market, while Kesh King, which Emami positions as an Ayurvedic hair oil, has a 34 per cent share of the Rs 720 crore segment.
“We are disappointed with the government’s decision to levy 12 per cent GST on Ayurvedic medicines and products, which we feel will be adverse for the category,” said Lalit Malik, chief financial officer at Dabur India. Industry sources said Dabur incurred an average rate of 8 per cent tax (VAT and excise) on its Ayurvedic portfolio while Emami incurred 11.5 per cent.
“The impact will be more on Dabur for the Ayurvedic category. For Emami, it translates into a 0.5 per cent hike,” said an analyst with brokerage firm Prabhudas Lilladher. Shortly after the Union Finance Minister Arun Jaitley came up with the different rates under the GST structure, Patanjali Ayurved, flagbearer for this segment, expressed appealed to the government to reconsider.
Earlier, responding to a question from a research analyst during an investor’s conference call, Mohan Goenka, director at Emami, said, “If the government is really focusing on Ayurveda then we expect better rates.”
Analysts said it was early to predict how the market would react to price hikes, but the net impact would not be too negative for the sector.
Source : http://www.business-standard.com/article/economy-policy/ramdev-unhappy-gst-rates-dampen-ayurveda-firms-hopes-117052500066_1.html